BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21455638)

  • 21. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics.
    Shin N; Jo HJ; Kim WK; Park WY; Lee JH; Shin DH; Choi KU; Kim JY; Lee CH; Sol MY; Jeon TY; Kim DW; Huh GY; Kim GH; Lauwers GY; Park DY
    Am J Surg Pathol; 2011 Jul; 35(7):1021-9. PubMed ID: 21677540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
    He XX; Yang J; Ding YW; Liu W; Shen QY; Xia HH
    Gut; 2006 Jun; 55(6):797-802. PubMed ID: 16488898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells.
    Smith MF; Mitchell A; Li G; Ding S; Fitzmaurice AM; Ryan K; Crowe S; Goldberg JB
    J Biol Chem; 2003 Aug; 278(35):32552-60. PubMed ID: 12807870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argyrophilic nucleolar organizer regions in Helicobacter pylori-associated gastric lesions.
    Misra V; Bisht D; Misra SP; Dwivedi M; Bhatia R
    APMIS; 2000 Jun; 108(6):448-52. PubMed ID: 11028808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
    Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
    Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
    Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
    Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study.
    Lisovsky M; Dresser K; Baker S; Fisher A; Woda B; Banner B; Lauwers GY
    Mod Pathol; 2009 Jul; 22(7):977-84. PubMed ID: 19407852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.
    Guo DL; Dong M; Wang L; Sun LP; Yuan Y
    World J Gastroenterol; 2002 Dec; 8(6):1009-13. PubMed ID: 12439915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric precancerous lesions among Nigerians with chronic gastritis.
    Badmos KB; Ojo OS; Olasode BJ; Arigbabu AO
    Niger Postgrad Med J; 2012 Jun; 19(2):92-6. PubMed ID: 22728974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of gastric CDX2 expression: a study in Mozambique.
    Peleteiro B; Barros R; Carrilho C; Artiaga J; Cunha L; Modcoicar P; Ferreira R; Figueiredo C; Almeida R; La Vecchia C; David L; Barros H; Lunet N
    Eur J Cancer Prev; 2012 Nov; 21(6):532-40. PubMed ID: 22407102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection and expression of the angiogenic factor platelet-derived endothelial cell growth factor by pre-neoplastic gastric mucosal lesions and gastric carcinoma.
    Franceschi F; Genta RM; Gasbarrini A; Gentiloni Silveri N; Gasbarrini G; Sepulveda AR
    Dig Liver Dis; 2002 Sep; 34(9):621-5. PubMed ID: 12405247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
    Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
    Cassaro M; Rugge M; Tieppo C; Giacomelli L; Velo D; Nitti D; Farinati F
    J Clin Pathol; 2007 Jun; 60(6):615-21. PubMed ID: 17557866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
    Joo M; Kim H; Kim MK; Yu HJ; Kim JP
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of claudin-4 and beta-catenin in gastric premalignant lesions.
    Seckin Y; Arici S; Harputluoglu M; Yonem O; Yilmaz A; Ozer H; Karincaoglu M; Demirel U
    Acta Gastroenterol Belg; 2009; 72(4):407-12. PubMed ID: 20163034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human mode of intestinal type gastric carcinoma.
    Lai S
    Med Hypotheses; 2019 Feb; 123():27-29. PubMed ID: 30696587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
    Shiotani A; Uedo N; Iishi H; Tatsuta M; Ishiguro S; Nakae Y; Kamada T; Haruma K; Merchant JL
    Int J Cancer; 2007 Sep; 121(6):1182-9. PubMed ID: 17520681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases.
    Ohara T; Morishita T; Hashimoto H; Akimoto M; Kanoh Y; Nakajima N; Suzuki H; Hibi T
    Int J Mol Med; 2006 Jan; 17(1):53-8. PubMed ID: 16328011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.